Not all individuals with CLL call for therapy. Irrespective of all recent developments, the iwCLL nevertheless suggests watchful observation for sufferers with asymptomatic disorder.86 This advice is predicated on not less than two randomized trials evaluating observation to both chlorambucil monotherapy or fludarabine, cyclophosphamide and rituxim